| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/04/2013 | US20130084639 Bicyclic Derivatives as Modulators of Ion Channels |
| 04/04/2013 | US20130084346 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 04/04/2013 | DE4432732B4 3-Aryl-benzofuranone als Stabilisatoren 3-aryl-benzofuranones as stabilizers |
| 04/04/2013 | CA2850551A1 Pyridine derivatives |
| 04/04/2013 | CA2850541A1 Nitrogen mustard derivatives |
| 04/04/2013 | CA2850508A1 Imidazole derivatives as cyp17 inhibitors for the treatment of cancer |
| 04/04/2013 | CA2850166A1 Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer |
| 04/04/2013 | CA2850003A1 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses |
| 04/04/2013 | CA2849995A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| 04/04/2013 | CA2849820A1 Benzyl piperidine compounds as lysophosphatidic acid (lpa) receptor antagonist |
| 04/04/2013 | CA2849779A1 Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin-1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders |
| 04/04/2013 | CA2848604A1 Viral replication inhibitors |
| 04/04/2013 | CA2845191A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/03/2013 | EP2574607A1 PDE10 modulators |
| 04/03/2013 | CN103025729A Evaporable organically semiconductive material and use thereof in an optoelectronic component |
| 04/03/2013 | CN103025728A 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 04/03/2013 | CN103025725A Hetero ring compound |
| 04/03/2013 | CN103025724A 哌啶衍生物 Piperidine derivatives |
| 04/03/2013 | CN103025717A Heterocyclic alkanol derivatives as fungicides |
| 04/03/2013 | CN103025716A Bicyclic compound derivatives and their use as acc inhibitors |
| 04/03/2013 | CN103025383A Compounds for the treatment of clostridium difficile associated disease |
| 04/03/2013 | CN103012395A Preparation method of heterocyclic benzene compound |
| 04/03/2013 | CN103012394A Rhodanine derivative and preparation method thereof |
| 04/03/2013 | CN103012393A Isothiazole and pyrazole derivatives as fungicides |
| 04/03/2013 | CN103012392A Pyridine derivatives containing 1.2,3-thiadiazole, and preparation method and application thereof |
| 04/03/2013 | CN103012391A Pyrimidine derivatives containing 1.2,3-thiadiazole, and preparation method and application thereof |
| 04/03/2013 | CN103012376A Amide derivatives |
| 04/03/2013 | CN103012374A Piperizinylpiperidine derivatives as chemokine receptor antagonists |
| 04/03/2013 | CN103012365A Preparation method of optical switch molecular compound based on diarylethene Schiff base |
| 04/03/2013 | CN103012316A N-4-methyl-1,2,3-thiadiazole-4-acyl-N-substituted 1,3,4-thiadiazole thiourea derivative and preparation method and application thereof |
| 04/03/2013 | CN103012314A Sulfonamide compound and preparation method as well as application thereof |
| 04/03/2013 | CN103006645A Application of 2-aminobenzothiazole derivatives being taken as DHODH (dihydroorotate dehydrogenase) inhibitor |
| 04/03/2013 | CN102086195B Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
| 04/03/2013 | CN101553471B 抗菌喹啉衍生物 Antibacterial quinoline derivatives |
| 04/03/2013 | CN101255156B Composition containing thiazole rings, polymer, active layer, transistor, electronic device and method of preparing the same |
| 04/02/2013 | US8410272 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 04/02/2013 | US8410268 Process for the preparation of ziprasidone |
| 04/02/2013 | US8410266 2,4-pyrimidinediamine compounds and their uses |
| 04/02/2013 | US8410150 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 04/02/2013 | US8410143 Methylene urea derivatives |
| 04/02/2013 | US8410111 Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds |
| 04/02/2013 | US8410110 9-(piperazinylalkyl) carbazoles as Bax-modulators |
| 04/02/2013 | US8410090 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 04/02/2013 | US8410023 Compositions and methods for controlling nematodes |
| 04/02/2013 | CA2728541C Crystalline forms of thiazolidinedione compound and its manufacturing method |
| 04/02/2013 | CA2715143C Novel phenylpyrrole derivative |
| 04/02/2013 | CA2695720C Method of producing epothilone b by culturing sorangium cellulosum in a medium comprising propionic acid |
| 04/02/2013 | CA2585642C Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof |
| 04/02/2013 | CA2550843C Novel phenylalanine derivatives |
| 03/28/2013 | WO2013043744A2 Tricyclic compounds useful as neurogenic and neuroprotective agents |
| 03/28/2013 | WO2013042137A1 Bicyclic heterocycles as irak4 inhibitors |
| 03/28/2013 | WO2013041655A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
| 03/28/2013 | WO2013041537A1 Heterocyclocarbonylaminothiazoles, cosmetic or dermatological preparations containing said heterocyclocarbonylaminothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin |
| 03/28/2013 | WO2013041535A1 Aromatic amidothiazoles, cosmetic or dermatological preparations containing said aromatic amidothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin |
| 03/28/2013 | WO2013041468A1 Benzoic acid derivatives as eif4e inhibitors |
| 03/28/2013 | WO2013041042A1 Pyrazole carboxamides as janus kinase inhibitors |
| 03/28/2013 | WO2013040790A1 Substituted pyrimidines |
| 03/28/2013 | WO2013040789A1 Substituted pyrimidines |
| 03/28/2013 | WO2012172438A3 Compositions and methods for modulating a kinase |
| 03/28/2013 | WO2012041292A3 Compounds for diagnosing neurodegenerative diseases at the retina |
| 03/28/2013 | WO2011006935A3 Tetrazole derivatives |
| 03/28/2013 | US20130079375 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 03/28/2013 | US20130079351 2-acylaminothiazole derivative or salt thereof |
| 03/28/2013 | US20130079348 Compounds that modulate intracellular calcium |
| 03/28/2013 | US20130079346 Benzoic acid derivatives |
| 03/28/2013 | US20130079340 Benzothiazoles Having Histamine H3 Receptor Activity |
| 03/28/2013 | US20130079328 Compositions and methods for modulating the wnt signaling pathway |
| 03/28/2013 | US20130079321 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 03/28/2013 | US20130079313 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 03/28/2013 | US20130079303 Inhibitors of PI3 Kinase and/or mTOR |
| 03/28/2013 | US20130074927 Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency |
| 03/28/2013 | CA2849169A1 Pyrazole carboxamides as janus kinase inhibitors |
| 03/28/2013 | CA2847797A1 Benzoic acid derivatives as eif4e inhibitors |
| 03/28/2013 | CA2845720A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
| 03/27/2013 | EP2573559A1 Modulation of chemosensory receptors and ligands associated |
| 03/27/2013 | EP2573087A1 Pyridin-2-yl-amino-1,2,4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
| 03/27/2013 | EP2573086A1 N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| 03/27/2013 | EP2573085A1 N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
| 03/27/2013 | EP2571873A1 Bis(difluoromethyl) pyrazoles as fungicides |
| 03/27/2013 | EP2571866A1 Fungicidal oximes and hydrazones |
| 03/27/2013 | CN1964956B Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 03/27/2013 | CN1681791B 8-羟基喹啉衍生物 8-hydroxyquinoline derivative |
| 03/27/2013 | CN103003272A BIS(difluoromethyl) pyrazoles as fungicides |
| 03/27/2013 | CN103003271A Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of AIDS containing the rhodanine derivatives as active ingredients |
| 03/27/2013 | CN103003270A Benzofuranone compound and pharmaceutical composition containing same |
| 03/27/2013 | CN103003268A Isoxazole, isothiazole, furane and thiophene compounds as microbicides |
| 03/27/2013 | CN103003265A Microbicides |
| 03/27/2013 | CN103003263A Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests |
| 03/27/2013 | CN103003262A Nitrogenated aromatic heterocyclic ring derivative |
| 03/27/2013 | CN102993196A Triazole derivative, preparation method thereof, nano particles thereof and application of nano particles |
| 03/27/2013 | CN102993195A Substitutional-2-(chroman-6-oxyl) thiazole and application thereof as medicine |
| 03/27/2013 | CN102993194A Cyanuric-chloride-based benzothiazole ESIPT compounds, and preparation method and purpose thereof |
| 03/27/2013 | CN102993097A Pyrazole amide compound and application thereof |
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN102993081A Trimethine cyanine and its use |
| 03/27/2013 | CN102988362A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 03/27/2013 | CN102516505B Method for preparing donor-receptor alkylthiophene copolymer |
| 03/27/2013 | CN102026989B Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease |
| 03/27/2013 | CN101903347B Piperidinyl and piperazinyl modulators of gamma-secretase |
| 03/27/2013 | CN101875656B Preparation method of thiazolidinedione compound |